Japan Lifeline (TYO:7575) will implement a $10 million capital increase for its wholly owned U.S. subsidiary, JLL Med USA, according to a Tokyo bourse filing on Thursday.
Following the capital increase, JLL Med USA's capital will reach $10.4 million, equaling or exceeding 10% of the company's capital, making it a specified subsidiary.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.